Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login

August 2024

6th Year Perspective: Behind the Scenes at Pfizer...
August 1, 2024 - Professional Advice / Opinions

Featuring: Simkho Shimonov, PharmD Candidate c/o 2025 By: Rebecca Sabzanov, PharmD Candidate c/o 2026 Simkho Shimonov, a dedicated and diligent PharmD candidate at St. John’s University, is set to graduate in 2025. With an extensive background in both retail and hospital pharmacy, he has amassed a broad understanding of the field. Recently, Simkho further diversified…

Cystic Fibrosis Therapy Diminishes Hyper-Inflammation I...
August 1, 2024 - In the News / Politics

Michelle Flores, Pharm D Candidate c/o 2027 According to clinical trial results from researchers at UCL, UCLH, and the Francis Crick Institute in the UK, dornase alfa, a drug commonly used to treat cystic fibrosis, improved outcomes for patients with severe COVID-19 pneumonia and may be used to treat other respiratory infections. A randomized unblinded…

FDA Accelerated Approval of Enhertu for Broad Treatment...
August 1, 2024 - In the News / Politics

By: Nivaj Haque; PharmD Candidate c/o 2027 In recent years, advancements in oncology have transformed the treatment landscape for various cancers, including those overexpressing human epidermal growth factor receptor 2 (HER2). Approximately 15-20% of breast cancers and a significant proportion of gastric and lung cancers are HER2-positive, making this a critical target for innovative therapies.1…

FDA’s New Blueprint for Cell-Based Therapies...
August 1, 2024 - In the News / Politics

By: Reyaz Mussaleen PharmD Candidate c/o 2027 IntroductionThe Food and Drug Administration (FDA) of the United States published a draft guidance in April 2024 titled “Safety Testing of Human Allogeneic Cells Expanded for Use in Cell-Based Medical Products.”1 This document, which aims to improve the regulatory framework for cell-based therapies, demonstrates the FDA’s determination to…

From Weight Loss to Vision Loss: A Potential Risk of Se...
August 1, 2024 - Clinical , In the News / Politics

By: Sariah Grant, PharmD Candidate c/o 2027            In June 2021, the Food and Drug Administration approved Novo Nordisk’s semaglutide, marketed under the brand name Wegovy. It was approved for adults facing obesity and other weight-related conditions.1 Initially developed for the management of type 2 diabetes mellitus (T2D), semaglutide’s use has expanded significantly due to…

Rho Chi Talks: A Look into the St. John’s University ...
August 1, 2024 - Featured , Professional Advice / Opinions

By: Rosa Kang PharmD Candidate c/o 2027 Summer is a time of endless possibilities. During this time, St. John’s University offers a program for its students who are interested in pursuing research: The Summer Research Program! Here are just a few of the many experiences from the professors and students who are participating in this…



Do You Want to be a Published Author? Submit your Article(s) Today!



Tweets by @RhoChiPost

HOME: Home Page

VOLUMES / ISSUES: 14 . 13 . 12 . 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List


Copyright © 2011-2025 Rho Chi Post